<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220221054085N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-27</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Acupuncture Points (Hegu and Sanyinhiao) on Duration, labor Pain Intensity and  Need for Induction of the First Stage of Labor</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Acupuncture Points (Hegu and Sanyinhiao) on Duration, labor Pain Intensity and  Need for Induction of the First Stage of Labor: A Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>124</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62081</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Previous studies have focused on determining the effect of the TENS device on reducing labor pain, while in this study we have tried to consider its effect on labor duration and the need to induce labor, Randomization description: Samples are randomly entered into three groups of 42, so that in order to randomize the selection of samples by simple lottery method in one of the intervention groups 1 (Hugo point electrical stimulation), intervention 2 (San Ingiao electrical stimulation) or placebo group Placed. َAfter assessing the participants according to inclusion criteria and taking consent, we will exclude a ball from a bag. the red ball means first group, green ball means second group, and the white one means placebo group, Blinding description: In this study, one-way blinding will be performed and participants will be unaware that the device is turned on or not.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Pain intensity and duration of labour and the need for induction in the active phase of labor.</hc_freetext>
      <i_freetext>Intervention 1: Intervention groups 1 (Hugo point electrical stimulation): In this study, the portable two-channel Max Tens 2000 device, which works with a battery, will be used with two pairs of electrodes. At the beginning of the intervention, when the person is in cervical dilatation of 3-4 cm, two electrodes will be placed in the Hugo area (located in the membrane between the thumb and index finger between the junction of the first and second metacarpal bones) in both hands and with continuous current, the frequency 100 Hz per minute and a wavelength of 250 microseconds will be set and alternately on for 20 minutes and off for 20 minutes, and this will continue until the end of the second stage of labor (dilation of 10 cm to the exit of the fetus). Intervention 2: Intervention 2 (San Injiao Electrical Stimulation): In this study, a portable two-channel Max Tens 2000 device that works with a battery and two pairs of electrodes will be used. At the beginning of the intervention, since the dilatation of the cervix is 3-4cm, two electrodes will be placed in the San Injiao area in both legs (at a distance of 4 fingers from the fingers of the same person above the inner ankle) and with continuous current, the frequency of 100 Hz It will be set to 250 microseconds per minute and the wavelength will be alternately on for 20 minutes and off for 20 minutes, and this will continue until the end of the second stage of labor (dilation of 10 cm to the exit of the fetus). Intervention 3: Control group: Placebo: In this study, the portable two-channel Max Tens device that works with a battery and two pairs of electrodes will be used. In this group, from the time of 3-4 cm dilatation of the cervix, two electrodes will be installed on the Hugo points on the hands and two electrodes on the San Injiao points on both feet, but no electric current will be established and the client will not know about the absence of current. Because we will turn on the device. And after the completion of the second stage of labor, the electrodes will be removed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Personal information will not be identifiable after encryption.

When:
tarting 6 months after publication

To whom:
There are no restrictions on data presentation. Information can be provided after the publication of the article

Conditions:
Data are presented for comparison and systematic studies

Where to obtain:
To receive data, you can contact Sanaz Fayazi, az email address sanaz faiiazi@gmail.com 09128216204پ

How to obtain:
After the publication of the article, the data will be submitted within 10 days if the applicants receive an email or a call.

Comments:
No comment</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sanaz Fayazi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>mahdavi Blv.</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4513956184</zip>
        <telephone>+98 24 3314 8375</telephone>
        <email>sanazfaiiazi@gmail.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Najmi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Gavazang Blv. Mousavi Hospital</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4513956184</zip>
        <telephone>+98 24 3314 8371</telephone>
        <email>zahranajmi@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age is 18-35 years
BMI below 30
Height above 150
Gestational age is 42-37 weeks.
Be primiparous
cephalic presentation
No CPD based on examination by researcher and on-call Obstetrics
Less than 6 hours have passed since the rupture of the membranes
Education level is at least fifth elementary.
Iranian
no induction during labor
no epilepsy.
any use of painkillers since 3 hours before labor starts
Must not be a user of cardiac pacemakers
not  to be addict
no skin problem or scar in the region of electrodes
contractions have started spontaneously
single fetus
no experience of using TENS before
dilatation 3-5 cm</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>no tendency to continue participating in the study
using the oxytocin or prostaglandin be necessary
using any drug during the labor
childbirth by cesarean method
allergy or burn in the region of TENS electrodes</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>075.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>075.8 Other specified complications of labour and delivery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention groups 1 (Hugo point electrical stimulation): In this study, the portable two-channel Max Tens 2000 device, which works with a battery, will be used with two pairs of electrodes. At the beginning of the intervention, when the person is in cervical dilatation of 3-4 cm, two electrodes will be placed in the Hugo area (located in the membrane between the thumb and index finger between the junction of the first and second metacarpal bones) in both hands and with continuous current, the frequency 100 Hz per minute and a wavelength of 250 microseconds will be set and alternately on for 20 minutes and off for 20 minutes, and this will continue until the end of the second stage of labor (dilation of 10 cm to the exit of the fetus).</i_keyword>
      <i_keyword>Intervention 2 (San Injiao Electrical Stimulation): In this study, a portable two-channel Max Tens 2000 device that works with a battery and two pairs of electrodes will be used. At the beginning of the intervention, since the dilatation of the cervix is 3-4cm, two electrodes will be placed in the San Injiao area in both legs (at a distance of 4 fingers from the fingers of the same person above the inner ankle) and with continuous current, the frequency of 100 Hz It will be set to 250 microseconds per minute and the wavelength will be alternately on for 20 minutes and off for 20 minutes, and this will continue until the end of the second stage of labor (dilation of 10 cm to the exit of the fetus).</i_keyword>
      <i_keyword>Control group: Placebo: In this study, the portable two-channel Max Tens device that works with a battery and two pairs of electrodes will be used. In this group, from the time of 3-4 cm dilatation of the cervix, two electrodes will be installed on the Hugo points on the hands and two electrodes on the San Injiao points on both feet, but no electric current will be established and the client will not know about the absence of current. Because we will turn on the device. And after the completion of the second stage of labor, the electrodes will be removed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Duration of the first stage of labor: Accurate recording of the start time of the active phase from dilatation of 4 cm to complete dilatation of the cervix (will be measured on a minute scale). Timepoint: from dilatation of 4 cm to complete dilatation of the cervix. Method of measurement: TV.</prim_outcome>
      <prim_outcome>Pain ruler is a visual tool for determining the severity of pain through self-reporting. Scores range from 0 to 10. A score of 3-0 indicates mild pain, 4-7 indicates moderate pain, and 8-10 indicates severe pain. Timepoint: from dilatation of 4 cm to complete dilatation of the cervix. Method of measurement: macGil ruler.</prim_outcome>
      <prim_outcome>According to the diagnosis of the treating physician and recording the order to start induction of labor in the patient's file. Timepoint: from dilatation of 4 cm to complete dilatation of the cervix. Method of measurement: Trans vaginal examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-06-15</approval_date>
        <contact_name>Ethical committee of Zanjan university of medical sciences</contact_name>
        <contact_address>No12, Khaje nasir Street, Maraghe East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
